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The beating heart muscle is an ever-
intriguing sight. Be it an observation in 
situ during open-chest surgery, in the lab 
as a Langendorff perfusion experiment, 
or under the microscope as a twitching 
muscle or single cell, its dynamic nature 
demands attention of the observer. As such, 
it is not surprising that it was the subject 
of intense investigation since the dawn of 
physiology. Over the centuries, tools and 
techniques have undergone developments 
that now allow the investigation of not 
only the primary physiological output of 
cardiac muscle, i.e. the ability to contract 
and relax rhythmically, but also investigate 
the molecular and cellular events that lead 
up to force development. We can investigate 
electrical activity of tissues, cells, and single 
channels, we can investigate the mechani-
cal activity at the ventricular, cellular, and 
even molecular level, and follow various 
biochemical events and ion movements 
during contractile cycles. Where we have 
made the greatest strides in the past centu-
ries is to better understand the structure and 
function of the various proteins involved 
in bringing about this intriguing organ’s 
function. We have developed the tools to 
make single amino-acid modifications, 
and study the resulting altered biochemi-
cal, mechanical, and electrical function. The 
new tools developed have however come at 
a price; while the more reduced approach 
allows for a better control of experimental 
conditions needed to carefully and unam-
biguously carry out the experiments, it also 
strips the reduced preparation of many of 
its interactors and governors, and as such 
the result of the molecular intervention of 
the organ   system as a whole becomes hard, 
if not impossible, to assess. Herein thus lies 
our future challenge; how can we integrate 
the molecular intervention to change the 
components of the system with the assess-
ment of change that is a specific result of 
the intervention in physiological function 
of the intact system. Clearly, transgenic mice 
or knock-out mice have fulfilled this role 
to a certain extend, and with much insight 
gained. However, significant differences 
between function and protein composi-
tion in mice versus human and the com-
pensatory changes that occur during as a 
result of the genetic manipulation impose 
2 important limitations on this tool. In the 
decades to come, we are expecting to see 
significant improvements in gene-delivery 
techniques that may overcome many of 
our current limitations to link an altered 
molecular composition directly to the 
resulting altered physiological function. 
Virus-mediated gene delivery, using a grow-
ing number of vectors and vector systems is 
emerging as a powerful tool to help us tackle 
the challenge. Multiple protein expression 
strategies, including overexpression, specific 
knock-down, and mutagenesis, in combi-
nation with emerging molecular tools such 
as siRNA’s and organ-specific delivery vec-
tors, are increasingly being used and further 
developed. The other side of the challenge is 
the assessment of altered function. Here too 
new techniques and methods are emerging 
to help us meet the overall challenge. Novel 
microscopy techniques are emerging, allow-
ing us to observe functional processes in 
live cells and live tissue with greater spacial 
and temporal  resolution. Other  assessment 
  techniques too are being increasingly 
employed, such as the ability to study in 
vitro processes under near-  physiological 
conditions, whereas in the past these may 
have been performed under conditions 
remote from the normal in vivo condition. 
These techniques better allow the extrapola-
tion of functional data to the in vivo situa-
tion, and facilitate the translational aspect 
of the findings.
In summary, the challenge of the field 
lies in how we are going to find better ways 
to link the molecular intervention tools that 
can change the components of the system to 
the assessment of physiological significance 
that is a specific result of such an interven-
tion. Only if we can unambiguously link a 
molecular perturbation of the system to a 
change in function that is assessed under 
conditions functionally relevant to the sys-
tem as a whole can we further make strides 
in understanding cardiac muscle function. 
The tools on both sides of the challenge, 
molecular intervention and assessment of 
function, are rapidly emerging, leading me to 
conclude that there are exciting times ahead 
in the area of cardiac muscle physiology.
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